Journey Medical Corp (DERM)

Currency in USD
7.280
-0.020(-0.27%)
Real-time Data·
DERM Scorecard
Full Analysis
Operates with a moderate level of debt
DERM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7.2457.475
52 wk Range
3.5358.249
Key Statistics
Prev. Close
7.3
Open
7.36
Day's Range
7.245-7.475
52 wk Range
3.535-8.249
Volume
14.99K
Average Volume (3m)
135.2K
1-Year Change
48.37%
Book Value / Share
0.93
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DERM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.500
Upside
+44.23%
Members' Sentiments
Bearish
Bullish
ProTips
Not profitable over the last twelve months

Journey Medical Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Journey Medical Corp Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Employees
41

Journey Medical Corp Earnings Call Summary for Q1/2025

  • Q1 2025 revenue beat at $13.1M, but EPS missed at -$0.18; stock rose 8.88% in aftermarket trading to $6.50
  • Gross margin improved to 64% from 54% YoY; successful launch of AMROCI rosacea treatment contributed to performance
  • Company aims for EBITDA positivity later in 2025; projects improved EPS for FY2026
  • Cash position at $21.1M; debt-to-equity ratio of 1.28 and current ratio of 1.37 indicate moderate debt and healthy liquidity
  • CEO calls 2025 'transformational'; analysts focus on AMROCI launch, QBREXZA trends, and potential Accutane competition
Last Updated: 14/05/2025, 22:40
Read Full Transcript

Compare DERM to Peers and Sector

Metrics to compare
DERM
Peers
Sector
Relationship
P/E Ratio
−20.4x−3.0x−0.5x
PEG Ratio
0.260.010.00
Price/Book
7.9x0.3x2.6x
Price / LTM Sales
3.0x1.3x3.3x
Upside (Analyst Target)
45.2%224.5%43.4%
Fair Value Upside
Unlock7.0%7.1%Unlock

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.500
(+44.23% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.18 / -0.10
Revenue / Forecast
13.10M / 12.06M
EPS Revisions
Last 90 days

DERM Income Statement

People Also Watch

18.31
URGN
-1.53%
61.345
CDTX
-0.62%
2.050
IPA
+10.81%
2.0070
DARE
-1.62%
5.385
ATYR
+2.77%

FAQ

What Stock Exchange Does Journey Medical Trade On?

Journey Medical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Journey Medical?

The stock symbol for Journey Medical is "DERM."

What Is the Journey Medical Market Cap?

As of today, Journey Medical market cap is 170.06M.

What Is Journey Medical's Earnings Per Share (TTM)?

The Journey Medical EPS (TTM) is -0.39.

When Is the Next Journey Medical Earnings Date?

Journey Medical will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is DERM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Journey Medical Stock Split?

Journey Medical has split 0 times.

How Many Employees Does Journey Medical Have?

Journey Medical has 41 employees.

What is the current trading status of Journey Medical (DERM)?

As of 08 Aug 2025, Journey Medical (DERM) is trading at a price of 7.28, with a previous close of 7.30. The stock has fluctuated within a day range of 7.25 to 7.48, while its 52-week range spans from 3.54 to 8.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.